This disappointed news release from Gilead on stalled hope remdesivir comes as such a big surprise.
Meanwhile, Trump refused to admit this afternoon that he has quietly stopped pushing hydroxychloroquine after tests showed it might increase mortality.
Now Pence — with a bit of help from the Department of Homeland Security — is touting warmth, humidity and sunlight as the virus's Kryptonite.
Remember the days when Ecuadorians were boasting how that was going to be their special protective shield? (22,000 cases and counting.)
This jab from OU is however quite promising. It may not be THE vaccine that the world so eagerly awaits; in truth it’s as much therapy as ‘cure’, but the thinking behind it is properly cunning.
Anyone who has been paying attention recently will know that the novel coronavirus sports a protein coat covered in protuberances, from which it derives its name.
The pointy heads at Oxford have come up with a way to refashion the similar coat worn by a common cold virus from the same stable, such that the memory cells of our immune system will be able to swot up on and memorise the relevant docking system in comparatively non-hazardous conditions. An infected person who has had the vaccine would thus have a significant head start in preventing serious disease.
The methodology neatly overcomes some of the risks and ethical issues associated with trialling a vaccine on high risk groups, such as the elderly and healthcare workers.
There’s no guarantee that the vaccinated would cease to be infectious, but some sort of reduction of spread is anticipated.